Terms: = Sarcomas AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
627 results:
1. Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
[TBL] [Abstract] [Full Text] [Related]
2. Decoding the Versatile Landscape of Autophagic Protein VMP1 in Cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms.
Renna FJ; Gonzalez CD; Vaccaro MI
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612567
[TBL] [Abstract] [Full Text] [Related]
3. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract] [Full Text] [Related]
4. BRAF V600E Mutation in Malignant Melanoma-A Romanian Research Experience.
Avădănei ER; Căruntu ID; Nucă I; Balan R; Lozneanu L; Giusca SE; Amalinei C
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541077
[No Abstract] [Full Text] [Related]
5. A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).
Greengard E; Williams R; Moriarity B; Liu X; Minard CG; Reid JM; Fisher T; Evans E; Pastore DR; Zauderer M; Voss S; Fox E; Weigel BJ
Pediatr Blood Cancer; 2024 Jun; 71(6):e30938. PubMed ID: 38520670
[TBL] [Abstract] [Full Text] [Related]
6. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
[TBL] [Abstract] [Full Text] [Related]
7. Integrating single-cell and spatial transcriptomes reveals COL4A1/2 facilitates the spatial organisation of stromal cells differentiation in breast phyllodes tumours.
Li X; Yu X; Bi J; Jiang X; Zhang L; Li Z; Shao M
Clin Transl Med; 2024 Mar; 14(3):e1611. PubMed ID: 38481388
[TBL] [Abstract] [Full Text] [Related]
8. Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF-mutation status?
Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
[TBL] [Abstract] [Full Text] [Related]
9. Duodenal malignant melanoma: Primary and metastatic case series and literature review.
Zhou B; Li X; Liu J; Peng L; Liu X
Medicine (Baltimore); 2024 Feb; 103(6):e37138. PubMed ID: 38335433
[TBL] [Abstract] [Full Text] [Related]
10. A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug
Sabnis N; Raut S; Nagarajan B; Kapic A; Dossou AS; Lothstein L; Fudala R; Bunnell BA; Lacko AG
Bioconjug Chem; 2024 Feb; 35(2):187-202. PubMed ID: 38318778
[TBL] [Abstract] [Full Text] [Related]
11. FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis.
Cho U; Cha HJ; Kim HJ; Min SK; Kim HK; Jung HR; Park G; Kim JE
Clin Exp Med; 2024 Jan; 24(1):18. PubMed ID: 38280044
[TBL] [Abstract] [Full Text] [Related]
12. Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial.
Cho HJ; Yun KH; Shin SJ; Lee YH; Kim SH; Baek W; Han YD; Kim SK; Ryu HJ; Lee J; Cho I; Go H; Ko J; Jung I; Jeon MK; Rha SY; Kim HS
Nat Commun; 2024 Jan; 15(1):685. PubMed ID: 38263321
[TBL] [Abstract] [Full Text] [Related]
13. Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments.
Zhou C; Li M; Ren Y; Miao F; Wang Y; Wu T; Gou X; Li W
World J Surg Oncol; 2024 Jan; 22(1):25. PubMed ID: 38254190
[TBL] [Abstract] [Full Text] [Related]
14. Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.
Serbest Ceylanoglu K; Guneri Beser B; Singalavanija T; Juntipwong S; Worden FP; Demirci H
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):18-29. PubMed ID: 38241616
[TBL] [Abstract] [Full Text] [Related]
15. Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models.
Lee B; Lee C; Moon HM; Jo SY; Jang SJ; Suh YA
Cells; 2023 Dec; 12(24):. PubMed ID: 38132178
[TBL] [Abstract] [Full Text] [Related]
16. [Research Progress of BRAF Fusion in Non-small Cell Lung Cancer].
Xiao P; Zhong D
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):782-788. PubMed ID: 37989341
[TBL] [Abstract] [Full Text] [Related]
17. Detecting acquired V-Raf murine sarcoma viral oncogene homolog B1 V600E mutation associated with osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma: A case report.
Hagihara Y; Suetsugu T; Uto H; Kozono T; Masada Y; Satozono Y; Shinmura M; Koreeda Y; Mizuno K; Inoue H
Respir Investig; 2024 Jan; 62(1):13-15. PubMed ID: 37925883
[TBL] [Abstract] [Full Text] [Related]
18. Immune microenvironment of intimal sarcomas: Adaptive immune resistance with potential therapeutic implications.
Birkness-Gartman JE; Thomas DL; Engle LL; Voltaggio L; Thompson ED
Am J Clin Pathol; 2024 Mar; 161(3):256-263. PubMed ID: 37921094
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
20. CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer.
Lu Y; Zou R; Gu Q; Wang X; Zhang J; Ma R; Wang T; Wu J; Feng J; Zhang Y
Cell Death Dis; 2023 Sep; 14(9):611. PubMed ID: 37716979
[TBL] [Abstract] [Full Text] [Related]
[Next]
